Literature DB >> 9419374

The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity.

L de Lecea1, T S Kilduff, C Peyron, X Gao, P E Foye, P E Danielson, C Fukuhara, E L Battenberg, V T Gautvik, F S Bartlett, W N Frankel, A N van den Pol, F E Bloom, K M Gautvik, J G Sutcliffe.   

Abstract

We describe a hypothalamus-specific mRNA that encodes preprohypocretin, the putative precursor of a pair of peptides that share substantial amino acid identities with the gut hormone secretin. The hypocretin (Hcrt) protein products are restricted to neuronal cell bodies of the dorsal and lateral hypothalamic areas. The fibers of these neurons are widespread throughout the posterior hypothalamus and project to multiple targets in other areas, including brainstem and thalamus. Hcrt immunoreactivity is associated with large granular vesicles at synapses. One of the Hcrt peptides was excitatory when applied to cultured, synaptically coupled hypothalamic neurons, but not hippocampal neurons. These observations suggest that the hypocretins function within the CNS as neurotransmitters.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9419374      PMCID: PMC18213          DOI: 10.1073/pnas.95.1.322

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Cloning, mRNA expression, and chromosomal mapping of mouse and human preprocortistatin.

Authors:  L de Lecea; P Ruiz-Lozano; P E Danielson; J Peelle-Kirley; P E Foye; W N Frankel; J G Sutcliffe
Journal:  Genomics       Date:  1997-06-15       Impact factor: 5.736

2.  Targeted disruption of the melanocortin-4 receptor results in obesity in mice.

Authors:  D Huszar; C A Lynch; V Fairchild-Huntress; J H Dunmore; Q Fang; L R Berkemeier; W Gu; R A Kesterson; B A Boston; R D Cone; F J Smith; L A Campfield; P Burn; F Lee
Journal:  Cell       Date:  1997-01-10       Impact factor: 41.582

3.  Cholecystokinin: a putative satiety signal.

Authors:  G P Smith; J Gibbs
Journal:  Pharmacol Biochem Behav       Date:  1975       Impact factor: 3.533

4.  Bombesin suppresses feeding in rats.

Authors:  J Gibbs; D J Fauser; E A Rowe; B J Rolls; E T Rolls; S P Maddison
Journal:  Nature       Date:  1979-11-08       Impact factor: 49.962

5.  Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty.

Authors:  D R Britton; G F Koob; J Rivier; W Vale
Journal:  Life Sci       Date:  1982-07-26       Impact factor: 5.037

6.  Neuropeptide Y: a potent inducer of consummatory behavior in rats.

Authors:  A S Levine; J E Morley
Journal:  Peptides       Date:  1984 Nov-Dec       Impact factor: 3.750

7.  Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats.

Authors:  J T Clark; P S Kalra; W R Crowley; S P Kalra
Journal:  Endocrinology       Date:  1984-07       Impact factor: 4.736

8.  Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain.

Authors:  K G Mountjoy; M T Mortrud; M J Low; R B Simerly; R D Cone
Journal:  Mol Endocrinol       Date:  1994-10

9.  Receptors for secretin, calcitonin, parathyroid hormone (PTH)/PTH-related peptide, vasoactive intestinal peptide, glucagonlike peptide 1, growth hormone-releasing hormone, and glucagon belong to a newly discovered G-protein-linked receptor family.

Authors:  G V Segre; S R Goldring
Journal:  Trends Endocrinol Metab       Date:  1993-12       Impact factor: 12.015

Review 10.  Influence of immune signals on the hypothalamic-pituitary axis of the rodent.

Authors:  C Rivier
Journal:  Front Neuroendocrinol       Date:  1995-04       Impact factor: 8.606

View more
  964 in total

1.  Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons.

Authors:  P Bourgin; S Huitrón-Résendiz; A D Spier; V Fabre; B Morte; J R Criado; J G Sutcliffe; S J Henriksen; L de Lecea
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

Review 2.  Promising new approaches to the management of obesity.

Authors:  I L Mertens; L F Van Gaal
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

Review 3.  Open-system approaches to gene expression in the CNS.

Authors:  J G Sutcliffe
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

Review 4.  Drug treatment of obesity: from past failures to future successes?

Authors:  P Collins; G Williams
Journal:  Br J Clin Pharmacol       Date:  2001-01       Impact factor: 4.335

5.  Hypocretin receptor 2 antagonism dose-dependently reduces escalated heroin self-administration in rats.

Authors:  Brooke E Schmeichel; Estelle Barbier; Kaushik K Misra; Candice Contet; Joel E Schlosburg; Dimitri Grigoriadis; John P Williams; Camilla Karlsson; Caleb Pitcairn; Markus Heilig; George F Koob; Leandro F Vendruscolo
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

Review 6.  Chemistry and biology of orexin signaling.

Authors:  Thomas Kodadek; Di Cai
Journal:  Mol Biosyst       Date:  2010-06-07

7.  Reduced hypocretin (orexin) levels in dementia with Lewy bodies.

Authors:  Stephanie Lessig; Kiren Ubhi; Douglas Galasko; Anthony Adame; Emiley Pham; Kelly Remidios; Michael Chang; Lawrence A Hansen; Eliezer Masliah
Journal:  Neuroreport       Date:  2010-08-04       Impact factor: 1.837

8.  The orexin 1 receptor (HCRTR1) gene as a susceptibility gene contributing to polydipsia-hyponatremia in schizophrenia.

Authors:  Yuko Fukunaka; Takahiro Shinkai; Rudi Hwang; Hiroko Hori; Kensuke Utsunomiya; Shinichi Sakata; Yui Naoe; Kazuko Shimizu; Chima Matsumoto; Osamu Ohmori; Jun Nakamura
Journal:  Neuromolecular Med       Date:  2007-08-01       Impact factor: 3.843

Review 9.  Recent Advances in Pharmacotherapy for Migraine Prevention: From Pathophysiology to New Drugs.

Authors:  Jonathan Jia Yuan Ong; Diana Yi-Ting Wei; Peter J Goadsby
Journal:  Drugs       Date:  2018-03       Impact factor: 9.546

10.  Hedonic Eating: Sex Differences and Characterization of Orexin Activation and Signaling.

Authors:  Laura Buczek; Jennifer Migliaccio; Gorica D Petrovich
Journal:  Neuroscience       Date:  2020-04-10       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.